A61K 38/51
Lyases
Official title: Lyases (4)
A61K38/51 (Lyases) appears on 352 US grants and 571 published applications in this corpus.
Search patents in A61K- Granted patents
- 352
- Published applications
- 571
- Assignees
- 279
- Inventors
- 926
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 8 | 3 |
| 2002 | 8 | 11 |
| 2003 | 4 | 14 |
| 2004 | 5 | 18 |
| 2005 | 5 | 16 |
| 2006 | 6 | 15 |
| 2007 | 5 | 16 |
| 2008 | 8 | 21 |
| 2009 | 7 | 18 |
| 2010 | 14 | 15 |
| 2011 | 5 | 19 |
| 2012 | 10 | 12 |
| 2013 | 11 | 21 |
| 2014 | 11 | 26 |
| 2015 | 14 | 29 |
| 2016 | 17 | 28 |
| 2017 | 18 | 27 |
| 2018 | 18 | 34 |
| 2019 | 28 | 42 |
| 2020 | 27 | 32 |
| 2021 | 22 | 34 |
| 2022 | 17 | 27 |
| 2023 | 12 | 21 |
| 2024 | 14 | 26 |
| 2025 | 12 | 35 |
| 2026 | 10 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enumeration of genetically engineered microorganisms by live cell counting techniques1 Sep 2026US 12,721,882 B2Synlogic Operating Company, Inc.
- Compositions comprising a tweak ligand and methods of using same25 Aug 2026US 12,714,740 B2Children's Hospital Medical Center
- Method and composition for treating arginase 1 deficiency7 Jul 2026US 12,673,093 B2Immedica Pharma AB
- Use of low pH active alpha-1,4;/1,6-glycoside hydrolases (GLCH) as a feed additive for ruminants to enhance starch digestion23 Jun 2026US 12,661,389 B2International N&H Denmark Aps
- Compositions and methods for treatment of homocystinuria23 Jun 2026US 12,661,391 B2The Regents of the University of Colorado, a body corporate
- Method and composition for treating arginase 1 deficiency24 Sep 2026US 2026/0284160 A1Immedica Pharma AB
- Viral Vectors For Treating Neurogenic Detrusor Overactivity3 Sep 2026US 2026/0258426 A1Assistance Publique-Hopitaux de Paris
- Combinations for Antigen Based Therapy23 Jul 2026US 2026/0207721 A1Diamyd Medical AB
- Compositions and uses thereof16 Jul 2026US 2026/0199428 A1Skinbiotherapeutics PLC
- Bacterial lysins and uses thereof2 Jul 2026US 2026/0183372 A1Huazhong Agricultural University
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Method and compositions for the treatment and repair of defects or lesions in cartilage470US 5,206,023 A1993
- Methods and compositions for the treatment and repair of defects or lesions in cartilage399US 5,368,858 A1994
- Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier222US 5,853,746 A1998
- Methods of repairing connective tissues151US 5,916,557 AInternational Technology Management Associates, Ltd. · 1999